Journal profile · Medicine-Infectious Diseases
Frontiers in Antibiotics
ISSN 2813-2467 · Frontiers Media S.A. · Switzerland
Frontiers in Antibiotics: impact factor 3.9 (journal website); fully open access; APC charged, amount not published; median 65 days to acceptance (62 articles, last 24 months); 23 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Antibiotics is published by Frontiers Media S.A.. By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance and Pharmaceutical and Antibiotic Environmental Impacts, together about 48.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Antibiotics publishes articles across the spectrum of antibiotic research that explore solutions to antibiotic resistance, development, and delivery to improve the health of the global population. Led by Field Chief Editor Prof Stephen H. Gillespie (University of St Andrews, UK), Frontiers in Antibiotics serves as a transparent, reliable platform for scientific exchange across the breadth of the field to address the evolving challenges of antibiotic development and resistance. Antibiotic resistance is rising globally and the therapeutic pipeline is not keeping up. Humanity urgently needs to understand the problem and identify solutions. Genomic tools, the application of big data to the epidemiology of resistance, rapid resistance detection techniques, methods to understand pharmacokinetics and innovative genomic approaches to antibiotic synthesis are transforming the discipline. Areas of interest include, but are not limited to: all aspects of antibiotic resistance antibiotic development and characterization antibiotics in clinical settings pharmacology and pharmacokinetics. Frontiers in Antibiotics explicitly encourages the submission of study protocols. The editors also encourage contributions and active involvement from early career researchers in all stages of the review and editorial processes. The journal actively promotes the development and thoughtful application of modern research methods and encourages responsible, reproducible reporting of scientific results. Submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being, are particularly welcome. Frontiers in Antibiotics is indexed in the DOAJ. Manuscripts relating to general pharmacology, with no application of antibiotics, are not suitable for publication in this journal. Frontiers in Antibiotics is committed to advancing developments in the field of antibiotic research by communicating scientific knowledge to researchers and the public alike to enable the scientific breakthroughs of the future. Frontiers in Antibiotics is a member of the Committee on Publication Ethics.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Infectious Diseases
Editorial board by country: 1 in mainland China (about 6%); most named United States 4, United Kingdom 2, Italy 2, Jordan 2, Mainland China 1 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology18.3%
- Antibiotic Use and ResistanceImmunology and Microbiology17.9%
- Pharmaceutical and Antibiotic Environmental ImpactsEnvironmental Science12.6%
- Antibiotics Pharmacokinetics and EfficacyMedicine6%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology5.6%
- Tuberculosis Research and EpidemiologyMedicine3.2%
- Antimicrobial Resistance in StaphylococcusMedicine2.8%
- Bacteriophages and microbial interactionsEnvironmental Science2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.9Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher)
- 5Publisher website ·
- SJR 2026-06
- 0.85LetPub ·
- SNIP 2026-06
- 1.2LetPub ·
- h-index
- 15OpenAlex ·
- i10-index
- 26OpenAlex ·
- 2-year mean citedness
- 3.35OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 98.65%LetPub ·
Volume
- Articles per year
- 23LetPub ·
Articles by year OpenAlex count · 137 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 30 |
| 2025 | 23 | 23 | 82 |
| 2024 | 30 | 30 | 203 |
| 2023 | 28 | 28 | 369 |
| 2022 | 15 | 15 | 196 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
65 daysMedian, submission to acceptance · P25–P75 42 days – 93 days
- Acceptance to online
- median 26 days (62 articles)
- Submission to online
- median 101 days
- Sample
- 62 articles with submission and acceptance dates (65 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,950 | Yes | CC BY | |
| OpenAlex | CHF 1,950 | — | — | |
| LetPub | USD 2,125 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Authorship
Authors must select appropriate article type and comply with word count limits. Model summary
Frontiers requires authors to select the appropriate article type for their manuscript and to comply with the article type descriptions defined in the journal's 'Article types' page
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures/tables published under CC-BY; permission needed for third-party copyrighted material. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Open access under CC-BY v4.0 since July 2012; authors retain copyright. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
English language standards required; external editing services recommended but do not guarantee acceptance. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2813-2467
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Antibiotics
What is the impact factor of Frontiers in Antibiotics?
The journal's website gives an impact factor of 3.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 5, h-index 15.
How long does peer review take at Frontiers in Antibiotics?
Based on the dates recorded on 62 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 65 days (interquartile range 42–93 days); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Antibiotics?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Antibiotics based?
Of the 16 board members whose country the journal's board page names, 1 (about 6%) are in mainland China; the countries named most often are United States (4), United Kingdom (2) and Italy (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Antibiotics?
According to LetPub and DOAJ records, Frontiers in Antibiotics is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Antibiotics open access, and what is the APC?
Frontiers in Antibiotics is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .